Cargando…

BMAL1 Knockdown Leans Epithelial–Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells

The circadian clock coordinates biological and physiological functions to day/night cycles. The perturbation of the circadian clock increases cancer risk and affects cancer progression. Here, we studied how BMAL1 knockdown (BMAL1-KD) by shRNA affects the epithelial–mesenchymal transition (EMT), a cr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuan, Devocelle, Aurore, Desterke, Christophe, de Souza, Lucas Eduardo Botelho, Hadadi, Éva, Acloque, Hervé, Foudi, Adlen, Xiang, Yao, Ballesta, Annabelle, Chang, Yunhua, Giron-Michel, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157026/ https://www.ncbi.nlm.nih.gov/pubmed/34065633 http://dx.doi.org/10.3390/ijms22105247

Ejemplares similares

BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways
por: Zhang, Yuan, et al.
Publicado: (2020)

Sex and Circadian Timing Modulate Oxaliplatin Hematological and Hematopoietic Toxicities
por: Dulong, Sandrine, et al.
Publicado: (2022)

Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis
por: Devocelle, Aurore, et al.
Publicado: (2019)

IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process
por: Le Coz, Vincent, et al.
Publicado: (2016)

Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells
por: Flamant, Stéphane, et al.
Publicado: (2019)

A30 EPITHELIAL FUNCTION OF THE CIRCADIAN CLOCK GENE, BMAL1, IS NECESSARY FOR COLONIC REGENERATION
por: Taleb, Z, et al.
Publicado: (2023)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance
por: Zhang, Canfeng, et al.
Publicado: (2023)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma
por: Hwang, Jin Wook, et al.
Publicado: (2019)

Effects of epiplakin-knockdown in cultured corneal epithelial cells
por: Kokado, Masahide, et al.
Publicado: (2016)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
por: Zhuang, Xiaodong, et al.
Publicado: (2021)

BMAL1/p53 mediating bronchial epithelial cell autophagy contributes to PM2.5-aggravated asthma
por: Chen, Shuai-Jun, et al.
Publicado: (2023)

The MiR-135b–BMAL1–YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance
por: Jiang, Weiliang, et al.
Publicado: (2018)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
por: Ip, Carman K. M., et al.
Publicado: (2016)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance
por: Zhang, Yan, et al.
Publicado: (2016)

Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
por: Dudás, József, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX
por: Escalante, Paula I., et al.
Publicado: (2021)

CFTR Knockdown induces proinflammatory changes in intestinal epithelial cells
por: Crites, Karoline St-Martin, et al.
Publicado: (2015)

Defining Hematopoietic Stem and Progenitor Cell Turnover by Analysis of Histone 2B-GFP Dilution
por: Foudi, Adlen, et al.
Publicado: (2008)

Core circadian clock transcription factor BMAL1 regulates mammary epithelial cell growth, differentiation, and milk component synthesis
por: Casey, Theresa, et al.
Publicado: (2021)

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
por: Gentil, Melanie, et al.
Publicado: (2018)

MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018)

Bmal1 knockdown in the left stellate ganglion inhibits neural activity and prevents ventricular arrhythmias after myocardial ischemia
por: Yu, Zhongyang, et al.
Publicado: (2022)

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
por: Antoon, James W., et al.
Publicado: (2012)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
por: Yokoyama, Yoshihito, et al.
Publicado: (2014)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
por: Cornelison, Robert, et al.
Publicado: (2017)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
por: Zhang, Zhengmao, et al.
Publicado: (2019)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p1o8hmorm9u4hku228385cd7se